SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Progenitor (PGEN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (50)3/20/1998 10:40:00 AM
From: Czechsinthemail  Respond to of 106
 
Here's the link to the news story:
biz.yahoo.com
"Progenitor today announced the publication of research suggesting that its patented, nonviral gene therapy system, T7T7, may be effective in the treatment of solid tumor cancer. The findings appear in today's issue of the peer-reviewed journal Human Gene Therapy (Volume 9: 729-736, 1998).



To: scaram(o)uche who wrote (50)3/20/1998 11:22:00 AM
From: Steve Lokness  Read Replies (2) | Respond to of 106
 
Richard;

Very good news indeed. To those who understand the science better than I do, what does this mean? Is this a blurp up or does this validate what PGEN is doing and will mean a sustained move?

Thanks and thanks to those who were positive on PGEN even as it drifted so low.

Good Investing;
Steve


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News